Takeda Pharmaceutical Company Limited Increase Decrease Through Net Exchange Differences Other Provisions
Takeda Pharmaceutical Company Limited (TAK) reported Increase Decrease Through Net Exchange Differences Other Provisions of -JPY 14.64 billion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions · last filed 2025-06-25
| Period end | Increase Decrease Through Net Exchange Differences Other Provisions 12 month |
|---|---|
| 2025-03-31 | -14.64B JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 91.78B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 37.19B JPY 20-F · filed 2024-06-26 |
| 2022-03-31 | 40.31B JPY 20-F · filed 2023-06-28 |
| 2021-03-31 | 16.46B JPY 20-F · filed 2022-06-29 |